DRREDDY's weekly performance was strong, with a return of 0.75%, outperforming peers DIVISLAB and HINDUNILVR, but underperforming SUNPHARMA. The stock's volatility was relatively low at 1.64%, indicating a relatively stable performance. With a Sharpe Ratio of 3.65, the stock's return was well-compensated for its risk. Overall, DRREDDY was a relatively low-risk stock this week.

[Volatility: 1.64%]